Mondebio operates within the biotechnology industry, focusing on the development and manufacturing of biopharmaceutical products. The company specializes in producing biosimilar medicines intended to provide alternative treatment options within the healthcare sector. Its primary clients include healthcare providers, hospitals, and pharmaceutical distributors seeking accessible therapeutic solutions. Mondebio’s work supports the broader pharmaceutical ecosystem by contributing to the availability of biologic treatments. The company’s activities are centered on research, development, and the commercialization of biosimilars in compliance with regulatory standards.